Brinker CEO Kevin Hochman: “We Are Firing on All Cylinders” After 20 Straight Quarters of Growth
Casual dining used to be a tough place to make money. Then Kevin Hochman took over Brinker Internati…
247wallst.com
CANF(CANF)
CANF
Signal
Bearish Setup2↓
PRICE
Prev Close
3.19
Open
3.24
Day Range2.89 – 3.24
2.89
3.24
52W Range2.83 – 24.00
2.83
24.00
0% of range
VOLUME & SIZE
Avg Volume
1.2M
FUNDAMENTALS
P/E Ratio
-0.3x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
Beta
0.47
Low vol
Performance
1D
-8.15%5D
-0.68%1M
-4.56%3M
-29.06%6M
-65.12%YTD
-26.75%1Y↓
-87.04%Worst: 1Y (-87.04%)
Quick Read
Trend—Insufficient MA data
Momentum
NEUTRAL
rev -16% · 100% gross marginValuation
FAIR
P/E not availableHealth
MODERATE
CR 3.5 · FCF negativeLean Bullish
Key MetricsTTM
Market Cap$8.18B
Revenue TTM$560.0K
Net Income TTM-$8.80M
Free Cash Flow-$8.36M
Gross Margin100.0%
Net Margin-1794.6%
Operating Margin-1815.2%
Return on Equity-141.0%
Return on Assets-71.9%
Debt / Equity0.01
Current Ratio3.46
EPS TTM$-0.00
Alpha SignalsView Intelligence →
Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.
Health Radar
3 strong3 concern
50/100Liquidity
3.46Strong
Leverage
0.01Strong
Coverage
0.0xConcern
ROE
-141.0%Concern
ROIC
-101.1%Concern
Cash
$6MStrong
ANALYST COVERAGE4 analysts
BUY
▲ +4848.8%upside to target
L $90.00
Med $145.00consensus
H $200.00Stock Health
Composite Score
4 of 5 signals bullish
8/10
Technicals
●
✗RSI RangeRSI 40 — Bearish momentum
Volume
●
✓Volume FlowAccumulation — institutional buying
Fundamentals
●
✓Last EarningsBeat estimates
●
✓Analyst ConsensusBuy
●
✓LiquidityCurrent Ratio 3.46 — healthy liquidity
Upcoming Events
EEarnings ReportMay 4, 2026
Tomorrow
DEx-Dividend DateJul 31, 2026
In 89 days
PDividend PaymentAug 17, 2026
In 106 days
FinancialsFull statements →
Technicals
Technical SetupBEARISH
Technicals →Trend
▼ DowntrendDeath Cross · 50D trails 200D by 54.8%
-17.2% vs SMA 50 · -62.5% vs SMA 200
Momentum
RSI39.6Momentum fading
MACD-0.13Below zero — bearish pulse · expanding
Market Position
Price Levels
52W High
$24.00+719.1%
EMA 200
$8.76+198.9%
EMA 50
$3.45+17.9%
Current
$2.93
52W Low
$2.83-3.4%
52-Week RangeNear 52-week low
$2.830th %ile$24.00
Squeeze SetupVolume-based
Moderate Squeeze SetupAccumulation pattern present — more buying days than selling over the past 20 sessions. Volume conditions support gradual price improvement.
20-Day Money Flow
Acc days:3
Dist days:1
Edge:+2 acc
Volume Context
Avg Vol (50D)5K
Recent Vol (5D)
4K-28%
Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.
Earnings & Analysts
ANALYST ESTIMATES
Consensus of 1 analyst
Analyst revisions:EPS↑ Revised UpRevenue↓ Revised Down
Analyst consensus estimates · Actuals replace estimates as reported
| Year | Revenue Est. | Rev Gth | EPS Est. | EPS Gth | Range | Analysts |
|---|---|---|---|---|---|---|
FY2025 | $202000 $202000–$202000 | — | -$0.52 | — | — | Low1 |
FY2026(current) | $20.6M $20.6M–$20.6M | ▲ +10100.0% | -$0.83 | — | — | Low1 |
FY2027 | $168.6M $168.6M–$168.6M | ▲ +718.1% | -$0.35 | — | — | Low1 |
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryCANF
Last 8Q
-108.3%avg beat
Beat 2 of 8 quartersMissed 5↑ Estimates rising-755%
Q2'23
+26%
Q3'23
—
Q4'23
-15%
Q1'24
-63%
Q2'24
-11%
Q3'24
-59%
Q4'24
+11%
Q2'25
Beat
Miss
Estimate
Deeper color = bigger beat/miss
* Negative EPS shown at reduced heightFinancials
INSTITUTIONAL OWNERSHIP
1
Bogart Wealth, LLC
0▼2
Activest Wealth Management
0▼3
FIFTH THIRD BANCORP
0▼4
Costello Asset Management, INC
0▼5
RHUMBLINE ADVISERS
282K▲6
JANE STREET GROUP, LLC
205K▲7
ADVISOR GROUP HOLDINGS, INC.
36K▲8
UBS Group AG
21K▲News & Activity
CANF News
20 articles · 4h ago
Jobs Report, Palantir, Pinterest, AMD, PayPal, Disney, and More to Watch This Week
barrons.com
Should You Dump Bitcoin for Stocks After the S&P 500 Hit a New Record on Apple's $100 Billion Buyback?
247wallst.com
Nostalgia Powers Big Debut for ‘The Devil Wears Prada 2'
wsj.com
Greg Abel earns solid scorecard from Berkshire shareholders after first annual meeting
cnbc.com
Belgian pharma group UCB to buy Candid Therapeutics for up to $2.2 billion
reuters.com
Why FormFactor Stock Plummeted This Week
fool.com
Why Poet Technologies Stock Crashed This Week
fool.com
This Often Underappreciated Growth Stock Is Holding Its Own Against Giants Amazon and Alphabet. Time to Buy?
fool.com
Buy These 3 Dividend Stocks Today and Thank Yourself in 20 Years
fool.com
This Overlooked Precious Metals ETF Offers a 7% Yield
247wallst.com
Bronstein, Gewirtz & Grossman LLC Urges Grocery Outlet Holding Corp. Investors to Act: Class Action Filed Alleging Investor Harm
newsfilecorp.com
Bronstein, Gewirtz & Grossman LLC Urges zSpace, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
newsfilecorp.com
Bronstein, Gewirtz & Grossman LLC Urges monday.com Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
Bronstein, Gewirtz & Grossman LLC Urges Eos Energy Enterprises, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
Bronstein, Gewirtz & Grossman LLC Urges Trip.com Group Limited Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
Bronstein, Gewirtz & Grossman LLC Urges Alight, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
Bronstein, Gewirtz & Grossman LLC Urges Boston Scientific Corporation Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
Bronstein, Gewirtz & Grossman LLC Urges ODDITY Tech Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
newsfilecorp.com
Bronstein, Gewirtz & Grossman LLC Urges Aldeyra Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
About
can fite biopharma (canfy) is a biotechnology company based out of 10 bareket street, פ"ת, israel.
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Pnina Fishman
Country
Israel
Website
Peers— —(7 companies)
Screen sector →| Symbol | Price | Day % | Mkt Cap↓ | P/E | Rev Grw | Margin | ELO |
|---|---|---|---|---|---|---|---|
CANF◀ | $2.93 | -8.15% | $2M | — | -3943.4% | -242667.2% | 1500 |
| $397.67 | +0.41% | $2.1T | 28.7 | +3296.8% | 4510.0% | 1500 | |
| $91.95 | +0.10% | $316.0B | 14.1 | +318.8% | 1510.7% | 1500 | |
| $131.46 | -0.32% | $305.1B | 22.6 | +586.3% | 1305.9% | 1500 | |
| $184.74 | -1.40% | $286.4B | 27.2 | +862.9% | 1745.9% | 1500 | |
| $146.57 | -0.87% | $279.7B | 21.0 | +597.3% | 2564.4% | 1500 | |
| $88.98 | -1.86% | $251.9B | 14.4 | -591.0% | 668.4% | 1500 | |
| Sector avg | — | -1.73% | — | 21.3 | +161.1% | -32908.9% | 1500 |